China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE: 000999)

Market Cap	56.89B
Revenue (ttm)	25.87B
Net Income (ttm)	3.41B
Shares Out	1.28B
EPS (ttm)	2.67
PE Ratio	16.59
Forward PE	16.05
Dividend	2.00 (4.52%)
Ex-Dividend Date	Nov 29, 2024

Volume	6,039,731
Average Volume	6,918,830
Open	43.76
Previous Close	44.18
Day's Range	43.76 - 44.97
52-Week Range	36.24 - 52.55
Beta	0.43
RSI	50.08
Earnings Date	Mar 13, 2025

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injecti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,318
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2023, SHE:000999's revenue was 24.74 billion, an increase of 36.83% compared to the previous year's 18.08 billion. Earnings were 2.85 billion, an increase of 16.50%.